USPTO serial 79299269
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical diagnostic device including to differentiate inflammation and infection in the body including joints, namely, medical diagnostic apparatus for testing and differentiating between joint inflammation and infection; medical analysis instrument and apparatus, namely, medical analysis instrument and apparatus for testing and differentiating between joint inflammation and infection; medical apparatus for diagnostic, detection, monitoring, measuring, testing and analysis purposes, namely, medical apparatus for diagnosing, detecting, monitoring, measuring, testing and analysing joint inflammation and infection; medical diagnostic testing apparatus, screening kits in this class for the detection and diagnosis of inflammation and infection in the body, namely, medical diagnostic testing apparatus and screening kit comprised of medical diagnostic apparatus for testing, detecting and differentiating sterile inflammatory joint pain from non-infective joint pain for detecting, diagnosing, testing and differentiating between joint inflammation and infection; orthopaedic apparatus inducing to diagnose inflammation and infection, namely, medical orthopaedic apparatus for testing, diagnosing and differentiating between joint inflammation and infection; biomarker diagnostic device being medical biomarker diagnostic apparatus for testing biomarkers to differentiate between joint inflammation and infection; genomic diagnostic device being medical genomic diagnostic apparatus for genomic testing to differentiate between joint inflammation and infection; medical diagnostic device being medical diagnostic apparatus for testing and differentiating between joint inflammation and infection for use in general, orthopaedic, renal, paediatric, neurological, trauma and other medical devices | ACTIVE | — |
| 044 | Medical diagnostic testing, monitoring and reporting services including providing information, reports, testing and analysis relating to inflammation and infection in the body; medical testing services in the field of testing for inflammation and infection in the body, design and development of medical diagnostic kits for others; provision of medical information and support in the nature of medical consulting and advisory services in the field of inflammation and infection; medical genomic diagnostic testing, monitoring and reporting services; information, advisory and consultancy services in relation to the aforementioned | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 23, 2023 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Apr 20, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 20, 2023 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Apr 19, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 21, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 26, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 26, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 14, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 21, 2022 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Dec 14, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 28, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 28, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 8, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 23, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 23, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 23, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 23, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 23, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 29, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 29, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 29, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2021 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jun 30, 2021 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Mar 20, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Feb 21, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 3, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 3, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 16, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 15, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 11, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 8, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 4, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 3, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |